The AVATAR Cell Control System lets you fine-tune oxygen and pressure to cater culture conditions to your cell type of interest. Customizing settings based on tumor type or native microenvironment allows cells to behave as they would in vivo.

Fluxion with IsoFlux has partnered with the Cleveland Clinic. They are aiming to improve sensitivity by timing the collection of liquid biopsy specimens to coincide with the point that the circulating volume tumor DNA is at its highest concentration

Genetically modified immune cells can successfully destroy colon cancer cells. This has been demonstrated for the first time by scientists from the German Cancer Consortium (DKTK) at Georg Speyer House in Frankfurt.

BioFlux DCIS is a fully-integrated high content screening platform for bridging the gap between in vitro and in vivo experiments. It combines a compact, high-quality imager with the proven flow control of the BioFlux system.

The qNano Gold measures particles using the Tunable Resistive Pulse Sensing (TRPS) principle. TRPS is the most powerful particle measurement system available for nano and sub-micron particle measurement and analysis. 

Immunotherapy for cancers involves artificially prompting the immune system to treat cancer. Many cancer cells have surface tumor antigen molecules, which can be detected by the immune system’s antibody proteins, which bind to the antigen. 

This event offers an overview of how live-cell analysis enables real-time analysis for the full workflow of the cells. Start at the beginning and learn more about the cell health, growth and morphology of your cells in culture.